Connor, Clark & Lunn Investment Management (CC&L)’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-77,734
Closed -$3.97M 1645
2024
Q4
$3.97M Sell
77,734
-7,234
-9% -$356K 0.02% 546
2024
Q3
$3.5M Buy
84,968
+8,465
+11% +$406K 0.02% 527
2024
Q2
$3.68M Buy
76,503
+8,276
+12% +$367K 0.02% 502
2024
Q1
$3.27M Buy
+68,227
New +$3.64M 0.01% 531
2023
Q3
Sell
-56,953
Closed -$3.31M 1579
2023
Q2
$3.31M Buy
56,953
+29,514
+108% +$1.86M 0.02% 478
2023
Q1
$1.69M Buy
+27,439
New +$1.65M 0.01% 590

Other funds holding NARI

Connor, Clark & Lunn Investment Management (CC&L)'s NARI Position: Q1 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 77,734 shares — an estimated $3.97M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NARI in Q1 2023 and held it in 6 quarters. The position peaked at $3.97M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 77,734 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $3.97M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Inari Medical, Inc. Common Stock in Q1 2023 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Inari Medical, Inc. Common Stock position peaked at $3.97M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.